145 related articles for article (PubMed ID: 28127551)
1. Elevated Plasma Neutrophil Gelatinase-Associated Lipocalin Level as a Risk Factor for Anemia in Patients with Systemic Inflammation.
Choi JW; Fujii T; Fujii N
Biomed Res Int; 2016; 2016():9195219. PubMed ID: 28127551
[TBL] [Abstract][Full Text] [Related]
2. Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.
Kim IY; Kim JH; Lee DW; Lee SB; Rhee H; Song SH; Seong EY; Kwak IS
Clin Exp Nephrol; 2018 Feb; 22(1):28-34. PubMed ID: 28389813
[TBL] [Abstract][Full Text] [Related]
3. The Prevalence of Low Plasma Neutrophil Gelatinase-Associated Lipocalin Level in Systemic Inflammation and its Relationship with Proinflammatory Cytokines, Procalcitonin, Nutritional Status, and Leukocyte Profiles.
Choi JW; Fujii T
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232043
[TBL] [Abstract][Full Text] [Related]
4. Associations of Plasma Neutrophil Gelatinase-associated Lipocalin, Anemia, and Renal Scarring in Children with Febrile Urinary Tract Infections.
Lee JH; Yim HE; Yoo KH
J Korean Med Sci; 2020 Mar; 35(10):e65. PubMed ID: 32174064
[TBL] [Abstract][Full Text] [Related]
5. Significance of Neutrophil Gelatinase-Associated Lipocalin Level-to-Serum Creatinine Ratio for Assessing Severity of Inflammation in Patients with Renal Dysfunction.
Choi JW; Fujii T; Fujii N
Biomed Res Int; 2015; 2015():791926. PubMed ID: 26491688
[TBL] [Abstract][Full Text] [Related]
6. Corrected Neutrophil Gelatinase-Associated Lipocalin (NGAL) Level Adjusted by the Scoring System of an Inflammation Index for Screening Renal Dysfunction in Patients with Systemic Inflammation.
Choi JW; Fujii T; Fujii N
Ann Clin Lab Sci; 2015; 45(3):248-55. PubMed ID: 26116587
[TBL] [Abstract][Full Text] [Related]
7. Association between systemic neutrophil gelatinase-associated lipocalin and anemia, relative hypochromia, and inflammation in chronic systolic heart failure.
Shrestha K; Borowski AG; Troughton RW; Klein AL; Tang WH
Congest Heart Fail; 2012; 18(5):239-44. PubMed ID: 22994438
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil gelatinase-associated lipocalin (NGAL) and cardiovascular events in patients with stable coronary artery disease.
Sivalingam Z; Erik Magnusson N; Grove EL; Hvas AM; Dalby Kristensen S; Bøjet Larsen S
Scand J Clin Lab Invest; 2018 Oct; 78(6):470-476. PubMed ID: 30261750
[TBL] [Abstract][Full Text] [Related]
9. A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.
Duvillard L; Ortega-Deballon P; Bourredjem A; Scherrer ML; Mantion G; Delhorme JB; Deguelte-Lardière S; Petit JM; Bonithon-Kopp C;
BMC Cancer; 2014 Dec; 14():912. PubMed ID: 25472811
[TBL] [Abstract][Full Text] [Related]
10. Urinary neutrophil gelatinase-associated lipocalin to hepcidin ratio as a biomarker of acute kidney injury in intensive care unit patients.
Mårtensson J; Glassford NJ; Jones S; Eastwood GM; Young H; Peck L; Ostland V; Westerman M; Venge P; Bellomo R
Minerva Anestesiol; 2015 Nov; 81(11):1192-200. PubMed ID: 25479470
[TBL] [Abstract][Full Text] [Related]
11. Increased NGAL level associated with iron store in chronic kidney disease with anemia.
Xiang D; Wang X; Liu P; Pan Y; Zhang Q; Chi X; Jing Y; Duan X; Wei Q; Wang J; Li M; Wang C
Clin Exp Med; 2018 Nov; 18(4):563-568. PubMed ID: 29909502
[TBL] [Abstract][Full Text] [Related]
12. Possible relationship between neutrophil gelatinase-associated lipocalin, hepcidin, and inflammation in haemodialysed patients.
Malyszko J; Malyszko JS; Kozminski P; Koc-Zorawska E; Mysliwiec M; Macdougall I
Nephron Clin Pract; 2010; 115(4):c268-75. PubMed ID: 20424477
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
14. Urinary neutrophil gelatinase-associated lipocalin, a biomarker for systemic inflammatory response syndrome in patients with nephrolithiasis.
Zhu W; Liu M; Wang GC; Che JP; Xu YF; Peng B; Zheng JH
J Surg Res; 2014 Mar; 187(1):237-43. PubMed ID: 24239146
[TBL] [Abstract][Full Text] [Related]
15. Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients.
Imamaki H; Ishii A; Yokoi H; Kasahara M; Kuwabara T; Mori KP; Kato Y; Kuwahara T; Satoh M; Nakatani K; Saito Y; Tomosugi N; Sugawara A; Nakao K; Mukoyama M; Yanagita M; Mori K
PLoS One; 2015; 10(7):e0132539. PubMed ID: 26161663
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass.
Tuladhar SM; Püntmann VO; Soni M; Punjabi PP; Bogle RG
J Cardiovasc Pharmacol; 2009 Mar; 53(3):261-6. PubMed ID: 19247188
[TBL] [Abstract][Full Text] [Related]
17. Plasma neutrophil gelatinase-associated lipocalinin in the general population: association with inflammation and prognosis.
Lindberg S; Jensen JS; Mogelvang R; Pedersen SH; Galatius S; Flyvbjerg A; Magnusson NE
Arterioscler Thromb Vasc Biol; 2014 Sep; 34(9):2135-42. PubMed ID: 24969771
[TBL] [Abstract][Full Text] [Related]
18. Plasma neutrophil gelatinase-associated lipocalin as a predictive biomarker for the detection of acute kidney injury in adult poisoning.
Ahn JY; Lee MJ; Seo JS; Choi D; Park JB
Clin Toxicol (Phila); 2016; 54(2):127-33. PubMed ID: 26683351
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
[TBL] [Abstract][Full Text] [Related]
20. Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study.
Kunutsor SK; Flores-Guerrero JL; Kieneker LM; Nilsen T; Hidden C; Sundrehagen E; Seidu S; Dullaart RPF; Bakker SJL
Clin Chim Acta; 2018 Nov; 486():66-75. PubMed ID: 30036522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
